Description
Neuro Drive Men is a research formula developed for laboratory studies on cognitive activity, neuronal communication, and the central nervous system in men. The combination of nootropic agents, peptides, and plant extracts is intended for studies on brain function, focus, and neuronal energy metabolism.
Product composition:
Brain Extract – 4 mg
Alpha GPC (L-Alpha Glycerylphosphorylcholine) – 6 mg
Modafinil (Microdose) – 1 mg
Orphanin FQ (Nociceptin) – 0.5 mg
Huperzine A – 0.2 mg
Bacopa monnieri – 8 mg
Ginkgo biloba – 6 mg
Clinically studied benefits in a laboratory environment:
1. Neuromuscular and cognitive activation: Alpha GPC is a cholinergic precursor studied for its role in acetylcholine synthesis and neuronal communication. In laboratory models, it supports cognitive speed and neuronal plasticity.
2. Improved concentration and resistance to mental fatigue: Modafinil (in microdose) is used in experimental settings to study attention and alertness. Combined with Alpha GPC, it shows potential for maintaining mental focus and efficient neuronal signaling.
3. Regulation of neuropeptide signaling: Orphanin FQ (Nociceptin) is a peptide studied for its role in modulating neuronal excitability and stress responses. Laboratory research shows possible regulatory effects on cognitive and emotional processes.
4. Neuroprotective and antioxidant effect: Huperzine A demonstrates acetylcholinesterase inhibition and protection of neuronal membranes. Combined with Bacopa monnieri, it enhances neurocellular resistance to oxidative factors.
5. Improved cerebral microcirculation and oxygen transport: Ginkgo biloba is studied for its role in neurovascular regulation and microcirculation. In laboratory models, it supports oxygen and nutrient delivery to brain tissues.
6. Adaptogenic and anti-stress activity: Bacopa monnieri and Ginkgo biloba exhibit adaptogenic properties that support cellular resilience under psychological and oxidative stress. Their combination is used in experimental studies on cognitive stress response.
7. Comprehensive support for neurotransmitter balance: The combination of Alpha GPC, Huperzine A, Modafinil, and Bacopa demonstrates synergistic potential for laboratory research on cholinergic, dopaminergic, and serotonergic pathways.
Dosage in the research protocol:
Recommended research protocol: Start with 7 units during the first week. From the second week onward, 10 units once daily.
Total amount per pen: 300 units.
Color variations of the solution compared to the image shown are possible. This is normal and does not affect the quality or composition of the product.
For laboratory purposes and personal observation only.
